ISRCTN70121840已完成不适用
Randomised controlled trial of glycerol adjuvant therapy in adult bacterial meningitis in Malawi
niversity of Malawi, College of Medicine (Malawi)0 个研究点目标入组 500 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients >=16 years old admitted with headache, fever and neck stiffness AND cerebrospinal fluid (CSF) findings suggestive of bacterial meningitis, defined as: cloudy CSF in a patient requiring immediate treatment or greater than 100 white cells/ml in the CSF with predominant neutrophils or gram-stain showing bacteria
- •2. Informed consent given (or in the case of unconscious patients, their guardian on their behalf), patient willing to follow study protocol
排除标准
- •1. Pregnant females
- •2. Type II diabetics
- •3. Patients with heart failure
- •4. Patients whose CSF results indicate infection by cryptococcus or mycobacteria
研究者
相似试验
已完成
不适用
Randomised controlled trial of Withania somnifera root powder in Parkinson?s DiseaseNervous System DiseasesParkinson's diseaseISRCTN31871098Higher Education Commission of Pakistan (HEC) (Pakistan)30
招募中
3 期
a phase 3 study of chemotherapy folowed by surgery and postoperative chemotherapy compared to initial surgery followed by chemotherapy in advanced ovarian cancerCTRI/2014/01/004363Sri Venkateswara Institute of Medical Sciences60
尚未招募
2 期
Prospective randomized trial of an adjuvant therapy of completely resected Merkel Cell Carcinoma (MCC) with immune checkpoint blocking antibodies (Nivolumab, Opdivo®; Ipilimumab, Yervoy®) versus observatioNL-OMON50102niversity Hospital Essen30
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlycompletely resected Merkel cell carcinomaMedDRA version: 21.1Level: LLTClassification code 10064025Term: Merkel cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000043-78-DEniversity of Essen190
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlyEUCTR2013-000043-78-NLniversity of Essen190